SCA
LH icon

Southpoint Capital Advisors’s Labcorp LH Stock Holding History

Southpoint Capital Advisors’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-500,000
Closed -$102M – 47
2024
Q2 		$102M Sell
500,000
-125,000
-20% -$25.4M 2.53% 15
2024
Q1 		$137M Sell
625,000
-275,000
-31% -$60.6M 2.7% 15
2023
Q4 		$205M Buy
900,000
+150,000
+20% +$31.5M 4.39% 7
2023
Q3 		$151M Sell
750,000
-448,430
-37% -$94.6M 3.37% 13
2023
Q2 		$248M Buy
1,198,430
+500,030
+72% +$97M 5.39% 4
2023
Q1 		$138M Buy
+698,400
New +$144M 3.12% 9

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Southpoint Capital Advisors's LH Position: Q3 2024 in Review

Southpoint Capital Advisors sold out of Labcorp (LH) in Q3 2024, closing a stake of 500,000 shares — an estimated $102M sold.

Southpoint Capital Advisors first reported a position in LH in Q1 2023 and held it in 6 quarters. The position peaked at $248M in Q2 2023. 918 funds tracked by Wall St. Rank hold LH as of Q3 2024.

  • Southpoint Capital Advisors reported no remaining Labcorp position as of Q3 2024 after selling out during the quarter.
  • Southpoint Capital Advisors sold 500,000 Labcorp shares in Q3 2024, an estimated $102M.
  • Southpoint Capital Advisors first reported a position in Labcorp in Q1 2023 and held it in 6 quarters.
  • Southpoint Capital Advisors's Labcorp position peaked at $248M in Q2 2023.
  • 918 funds tracked by Wall St. Rank held Labcorp as of Q3 2024.

Based on Southpoint Capital Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.